Bank of Montreal Can Sells 685,651 Shares of Kenvue Inc. $KVUE

Bank of Montreal Can reduced its holdings in Kenvue Inc. (NYSE:KVUE) by 36.5% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 1,193,124 shares of the company’s stock after selling 685,651 shares during the period. Bank of Montreal Can’s holdings in Kenvue were worth $24,972,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Kenvue by 4.9% in the first quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company’s stock worth $5,494,882,000 after acquiring an additional 10,600,682 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Kenvue by 2.5% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 25,606,238 shares of the company’s stock valued at $613,882,000 after purchasing an additional 633,461 shares during the period. Boston Partners boosted its holdings in Kenvue by 7.4% in the 1st quarter. Boston Partners now owns 25,346,453 shares of the company’s stock valued at $606,920,000 after purchasing an additional 1,750,490 shares during the period. JPMorgan Chase & Co. grew its position in Kenvue by 11.6% in the 1st quarter. JPMorgan Chase & Co. now owns 24,912,226 shares of the company’s stock worth $597,395,000 after purchasing an additional 2,597,920 shares during the last quarter. Finally, American Century Companies Inc. increased its holdings in shares of Kenvue by 15.7% during the 1st quarter. American Century Companies Inc. now owns 21,828,854 shares of the company’s stock worth $523,456,000 after purchasing an additional 2,961,716 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

KVUE has been the subject of several research reports. Barclays reduced their target price on shares of Kenvue from $20.00 to $17.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. Deutsche Bank Aktiengesellschaft set a $18.00 price target on Kenvue in a report on Friday, October 24th. Citigroup decreased their price objective on Kenvue from $20.00 to $17.00 and set a “neutral” rating on the stock in a report on Thursday, October 9th. Zacks Research upgraded Kenvue to a “strong sell” rating in a research note on Monday, August 11th. Finally, Johnson Rice reaffirmed a “neutral” rating on shares of Kenvue in a research report on Tuesday, October 28th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $20.17.

Kenvue Price Performance

Shares of KVUE stock opened at $16.50 on Friday. The stock’s fifty day simple moving average is $16.84 and its 200 day simple moving average is $20.34. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The firm has a market cap of $31.61 billion, a price-to-earnings ratio of 22.00, a P/E/G ratio of 2.38 and a beta of 0.71. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The company had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.83 billion. During the same period last year, the business earned $0.28 earnings per share. The business’s revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 26th. Shareholders of record on Wednesday, November 12th will be paid a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a yield of 5.0%. The ex-dividend date of this dividend is Wednesday, November 12th. Kenvue’s dividend payout ratio is currently 110.67%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.